NCT04791735

Brief Summary

Hepatocellular carcinoma treated by laparotomy or laparoscopic Multicenter prospective, open, superiority, controlled, randomized, clinical trial The primary objective of the study will be to demonstrate the superiority of the laparoscopic approach over the open approach in reducing postoperative morbidity in HCC patients. Postoperative morbidity will be assessed using the Comprehensive Complication Index (CCI) within 90 days postoperatively or at any time during hospitalization

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
252

participants targeted

Target at P75+ for not_applicable hepatocellular-carcinoma

Timeline
13mo left

Started May 2021

Longer than P75 for not_applicable hepatocellular-carcinoma

Geographic Reach
1 country

17 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
May 2021May 2027

First Submitted

Initial submission to the registry

January 7, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 10, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

May 21, 2021

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2027

Expected
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

3.9 years

First QC Date

January 7, 2021

Last Update Submit

May 22, 2025

Conditions

Keywords

laparoscopylaparotomy

Outcome Measures

Primary Outcomes (1)

  • The primary objective of the study will be to demonstrate the superiority of the laparoscopic approach over the open approach in reducing postoperative morbidity in HCC patients.

    Postoperative morbidity will be assessed using the Comprehensive Complication Index (CCI) within 90 days postoperatively or at any time during hospitalization

    90 days after inclusion

Secondary Outcomes (15)

  • Number of postoperative complications (grade at least 1 according to the Dindo-Clavien classification) within 90 days postoperatively or at any time during hospitalization.

    90 days after inclusion

  • Number of postoperative complications (grade at least 3 according to the Dindo-Clavien classification) within 90 days postoperatively or at any time during hospitalization.

    90 days after inclusion

  • All-cause mortality (grade 5 according to the Dindo-Clavien classification or a CCI of 100) within 90 days postoperatively or at any time during hospitalization.

    90 days after inclusion

  • Occurrence of specific liver related complications (ascites, liver failure, biliary fistula, hemorrhage) within 90 days postoperatively or at any time during hospitalization.

    90 days after inclusion

  • Occurrence of organ space and superficial surgical site infection (SSI) within 90 days postoperatively or at any time during hospitalization.

    90 days after inclusion

  • +10 more secondary outcomes

Study Arms (2)

Laparoscopic approach for liver resection of HCC

EXPERIMENTAL
Procedure: Laparoscopy

laparotomy

EXPERIMENTAL
Procedure: Laparotomy

Interventions

LaparoscopyPROCEDURE

* Installations of the patient: the position of the patient will depend on both extent of resection and location of the lesion. * Absence of laparotomy with the exception of the extraction of the resected specimen and absence of costal retractors. * Use of laparoscopic specific devices: * Use of multiple (3-7) ports depending on the operator's preference and technical difficulty (mainly 5-6 ports for major liver resection). * Use of a laparoscopic camera system with 0° or 30° * Use of a dedicated laparoscopic ultrasound probe. * Use of specific laparoscopic devices for coagulation, parenchymal transection and sealing. * Placement of the resected specimen in a plastic bag and extraction without fragmentation, depending on the surgeon's preferenceand the diameter of the resected specimen

Laparoscopic approach for liver resection of HCC
LaparotomyPROCEDURE

* Installation of the patient: patients will be placed in supine position, the surgeon operating on the right side of the patient and the assistant standing on the left side. * Incision: the type of incision will depend on both the nature of the resection and the operator's preference. Various incisions such as bi subcostal incision, J-shaped incision, right subcostal incision and midline incision can be used. * Use of open surgical instruments and devices for coagulation and parenchymal transection. These may include the crush-clamp technique or ultrasonic dissection for parenchymal transection, bipolar coagulation, clips, sutures or open vascular stapler for hemostasis and biliostasis. * Methylene blue injection through the cystic drain to rule out biliary leakage will be performed depending on the surgeon's preference.

laparotomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patient aged ≥ 18 years
  • Presenting with solitary or multifocal resectable HCC
  • Qualifying for both pure laparoscopic and open approaches

You may not qualify if:

  • Physical or psychological status contraindicating the participation to the study
  • Contraindication to surgery
  • Contraindication to pneumoperitoneum
  • ASA (American Society of Anesthesiologists) score IV-V
  • Life expectancy \< 2 months
  • Suspicion of mixed type tumor (Hepatocholangiocarcinoma) and fibrolamellar HCC
  • Child-Pugh score \> B7
  • Extra-hepatic involvement
  • Liver resection requiring an associated vascular or biliary reconstruction
  • Pregnancy and breast-feeding
  • Tutorship, trusteeship
  • Concurrent participation in other experimental trials concerning the same objective within 90 days following intervention
  • No Affiliation to the French social security
  • No Ability to give their consent and not written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

Chirurgie Digestive - CHU Amiens

Amiens, France, 80054, France

Location

Chirurgie viscérale et digestive - CHU Besançon

Besançon, France, 25000, France

Location

Chirurgie Hépatologie - Hôpital Beaujon

Clichy, France, 92110, France

Location

Chirurgie Digestive et Hépatobiliaire - Hôpital Henri-Mondor

Créteil, France, 94010, France

Location

Chirurgie Digestive et de l'Urgence - CHU Grenoble

Grenoble, France, 38700, France

Location

Chirurgie Digestive et Transplantations - Hôpital Huriez

Lille, France, 59021, France

Location

Chirurgie Générale, Digestive et de la Transplantation hépatique - Hôpital de la Croix Rousse

Lyon, France, 69317, France

Location

Chirurgie Digestive - CHU Montpellier

Montpellier, France, 34090, France

Location

Chirurgie digestive - Institut Mutualiste Montsouris

Paris, France, 75014, France

Location

Cochin hospital

Paris, France, 75014, France

Location

Chirurgie hépato-biliaire et greffe de foie - La Pitié

Paris, France, 75651, France

Location

Chirurgie viscérale et digestive - CHU Rouen

Rouen, France, 76000, France

Location

Chirurgie hépato-bilio-pancréatique et Transplantation - Hôpital Rangueil

Toulouse, France, 31059, France

Location

Chirurgie digestive Oncologique Endocrinienne et Transplantation hépatique - CHU Tours

Tours, France, 37000, France

Location

Centre hépatobiliaire de transplantation hépatique - Hopital Paul Brousse

Villejuif, France, 94800, France

Location

Chirurgie Digestive - Hôpital La Timone

Marseille, 13005, France

Location

CHU Rennes - Pontchaillou

Rennes, France

Location

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Interventions

LaparoscopyLaparotomy

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: the intervention group is Laparoscopic approach for liver resection of HCC The standard arm is the open approach for liver resection of HCC. Both this standard arm and the laparoscopic arm are in the realm of usual care.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2021

First Posted

March 10, 2021

Study Start

May 21, 2021

Primary Completion

April 30, 2025

Study Completion (Estimated)

May 7, 2027

Last Updated

May 28, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations